Uploaded by FinancialNewsOnline on Nov 28, 2011
GE Healthcare (NYSE:GE) announced an additional $300 million investment in low-dose technologies and unveiled an array of radiation-dose management offerings today at RSNA 2011.
Representing more than $800 million of investment over 15 years, GE Healthcare's innovative technologies redefine "low dose" with novel dose-reporting solutions, unique image reconstruction techniques, far reaching Dose Check upgrades, free iPad apps and online courses, and a new informational website, which together help physicians provide patients with unparalleled dose-conscious care.
General Electric (NYSE:GE) has potential upside of 40.1% based on a current price of $15.05 and an average consensus analyst price target of $21.09.
Representing more than $800 million of investment over 15 years, GE Healthcare's innovative technologies redefine "low dose" with novel dose-reporting solutions, unique image reconstruction techniques, far reaching Dose Check upgrades, free iPad apps and online courses, and a new informational website, which together help physicians provide patients with unparalleled dose-conscious care.
General Electric (NYSE:GE) has potential upside of 40.1% based on a current price of $15.05 and an average consensus analyst price target of $21.09.
No comments:
Post a Comment